A multicentre evaluation of metagenomic sequencing for pathogen detection in central nervous system infections
Clinical Microbiology and Infection · 2026-05 · 32 (5) · 797-805
DOI: 10.1016/j.cmi.2026.01.015 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Microbiology and Infection, 2026-05. Verfasst von Jiali Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of …. Hauptthemen laut MEDLINE: Metagenomics, Central Nervous System Infections, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Beijing Municipal Health Commission, National Health Commission of the People's Republic of China.
Abstract (Originalsprache)
OBJECTIVES: Metagenomic next-generation sequencing (mNGS) is a promising tool for diagnosing central nervous system infections. However, the low-biomass nature of cerebrospinal fluid (CSF) increases susceptibility to contamination and host-background interference, potentially compromising accuracy. This study aimed to evaluate CSF mNGS performance across multiple laboratories and to identify key factors influencing detection accuracy. METHODS: A reference panel of 15 CSF samples was designed to evaluate CSF mNGS performance across laboratories, including 3 replicate samples, 5 serial concentration-gradient samples, 3 anti-interference samples with added human serum albumin or increased host nucleic acids, and 3 simulated clinical case samples, along with 1 negative sample. A total of 127 laboratories participated, which apply mNGS in clinical diagnostics or research. Each laboratory used independently developed mNGS workflow, which varied in experimental procedures, bioinformatic pipelines, and positive detection thresholds. Accuracy, repeatability, sensitivity, and anti-interference capability were systematically evaluated, and sources of erroneous results and methodological factors influencing accuracy were analysed. RESULTS: Overall performance across 127 laboratories was favourable (average F1-score 0.98, reflecting overall accuracy by balancing sensitivity and specificity). Most false-positive results (83.43%) were due to experimental contamination, whereas false negatives were mainly attributed to RNA viruses (57.14%). Methodological factors significantly affected detection, with impact varying by microbial type. Generally, pelleting impaired the detection of all microbes. Notably, microbial enrichment through DNase treatment and Kraken2 improved detection accuracy for DNA viruses, bacteria, fungi and atypical pathogens, but had little effect on RNA viruses. CONCLUSIONS: This large-scale study underscores the need for improved contamination controls, optimized RNA virus detection, and enhancement of key wet-lab procedures to strengthen CSF mNGS reliability. These findings provide actionable insights to refine mNGS workflows and advance its clinical utility for diagnosing central nervous system infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, PR China; National Center for Clinical Laborator…
- Medical School, University of Chinese Academy of Sciences, Beijing, PR China.
- Department of Clinical Laboratory, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, PR China.
- Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.
- Department of Laboratory Medicine, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, PR China.
- Beijing Key Laboratory of Viral Infectious Diseases, Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Beijing Municipal Health Commission
- National Health Commission of the People's Republic of China
- National Science and Technology Major Project
- National Key Research and Development Program of China
Zitieren
APA
Wang, J., Ma, Y., Shi, X., Han, Y., Zhang, Y., Diao, Z., Li, Z., Lai, H., Meng, S., Zhang, C., Zhao, F., Qin, X., Li, J., & Zhang, R. (2026). A multicentre evaluation of metagenomic sequencing for pathogen detection in central nervous system infections. Clinical Microbiology and Infection, 32(5), 797-805. https://doi.org/10.1016/j.cmi.2026.01.015
Vancouver
Wang J, Ma Y, Shi X, Han Y, Zhang Y, Diao Z, et al. A multicentre evaluation of metagenomic sequencing for pathogen detection in central nervous system infections. Clinical Microbiology and Infection. 2026;32(5):797-805. doi:10.1016/j.cmi.2026.01.015
BibTeX
@article{Wang2026,
author = {Wang, Jiali and Ma, Yu and Shi, Xiankun and Han, Yanxi and Zhang, Yuanfeng and Diao, Zhenli and Li, Ziqiang and Lai, Huiying and Meng, Shuang and Zhang, Cuicai and Zhao, Fei and Qin, Xincheng and Li, Jinming and Zhang, Rui},
title = {A multicentre evaluation of metagenomic sequencing for pathogen detection in central nervous system infections},
journal = {Clinical Microbiology and Infection},
year = {2026},
volume = {32},
number = {5},
pages = {797--805},
doi = {10.1016/j.cmi.2026.01.015}
}
EUVIMED